Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant

Journal of the Neurological Sciences

Volumn 256, Issue 1-2, 2007, Pages 39-51

  Sanelli, Teresa ^a,b   Ge, Weiwen ^b   Leystra Lantz, Cheryl ^b   Strong, Michael J ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

ALS; AMPA; Calcium imaging; Excitotoxicity; Neurofilament; NMDA

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CALCIUM; CASPASE 3; DIZOCILPINE; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROFILAMENT PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHOLIPID; PROPIONIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; EXCITOTOXICITY; GENE OVEREXPRESSION; MOLECULAR WEIGHT; MOTONEURON; MOUSE; NERVE CELL; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; WILD TYPE;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; APOPTOSIS; CALCIUM; CELLS, CULTURED; DIZOCILPINE MALEATE; EMBRYO; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; NEUROFILAMENT PROTEINS; RECEPTORS, AMPA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; TIME FACTORS;

EID: 34147127042     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.02.018     Document Type: Article

References (53)

1. Strong M.J. Recent developments in the biochemistry and pharmacotherapy of amyotrophic lateral sclerosis. Expert Opin Investig Drugs 13 (2004) 1593-1614
2. Côte F., Collard J.-F., and Julien J.-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73 (1993) 35-46
3. Meier J., Couillard-Després S., Jacomy H., Gravel C., and Julien J.-P. Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol Exp Neurol 58 (1999) 1099-1110
4. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J Neuropathol Exp Neurol 64 (2005) 649-664
5. Delfs J.R., Saroff DM., Nishida Y., Friend J., and Geula C. Effects of NMDA and its antagonists on ventral horn cholinergic neurons in organotypic roller tube spinal cord cultures. J Neural Transm 104 (1997) 31-51
6. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., et al. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci 18 (1998) 2040-2055
7. Sasaki S., Warita H., Abe K., Komori T., and Iwata M. EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. NeuroReport 12 (2001) 1359-1362
8. Trotti D., Aoki M., Pasinelli P., Berger U.V., Danbolt N.C., and Brown Jr. R.H. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J Biol Chem 276 (2001) 576-582
9. Urushitani M., Nakamizo T., Inoue R., Sawada H., Kihara T., Honda K., et al. N-methyl-d-aspartate receptor-mediated mitochondrial Ca (2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res 63 (2001) 377-387
10. Kawahara Y., Ito K., Sun H., Kanazawa I., and Kwak S. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain. Eur J Neurosci 18 (2003) 23-33
11. Van Damme P., Leyssen M., Callewaert G., Robberecht W., and Van Den B.L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett 343 (2003) 81-84
12. Petri S., Krampfl K., Hashemi F., Schmalbach S., Grothe C., Hori A., et al. The mRNA expression of AMPA type glutamate receptors in the primary motor cortex of patients with amyotrophic lateral sclerosis: an in situ hybridization study. Neurosci Lett 360 (2004) 170-174
13. Arundine M., Sanelli T., He B.P., and Strong M.J. NMDA induces NOS 1 translocation to the cell membrane in NGF-differentiated PC12 cells. Brain Res 976 (2003) 149-158
14. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., and Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284 (1999) 1845-1848
15. Fletcher E.J., and Lodge D. New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacol Ther 70 (1996) 65-89
16. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17 (1994) 31-108
17. Arundine M., and Tymianski M. Molecular mechanisms of calcium-dependant neurodegeneration in excitotoxicity. J Pharmacol Exp Ther 300 (2002) 717-723
18. Lynch D.R., and Guttmann R.P. Excitotoxicity: perspectives based on N-methyl-d-aspartate receptor types. J Pharmacol Exp Ther 300 (2002) 717-723
19. Hume R.I., Dingledine R., and Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 253 (1991) 1028-1031
20. Vandenberghe W., Robberecht W., and Brorson J.R. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J Neurosci 20 (2000) 123-132
21. Shaw P.J., Forrest V., Ince P.G., Richardson J.P., and Wastell H.J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4 (1995) 209-216
22. Lin C.-L.G., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
23. Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 193 (2002) 73-78
24. Kwak S., and Kawahara Y. Deficient RNA editing of GluR2 and neuronal death in amyotrophic lateral sclerosis. J Mol Med 83 (2005) 110-120
25. Kawahara Y., Kwak S., Sun H., Ito K., Hashida H., Aizawa H., et al. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J Neurochem 85 (2003) 680-689
26. Tortarolo M., Grignaschi G., Calvaresi N., Zennaro E., Spaltro G., Colovic M., et al. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res 83 (2006) 134-146
27. Sanelli T., Sopper M.M., and Strong M.J. Sequestration of nNOS in neurofilamentous aggregate bearing neurons leads to enhanced glutamate-mediated calcium influx. Brain Res 1004 (2004) 8-17
28. McLean J.R., Leystra-Lantz C., He B.P., and Strong M.J. Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL+/+ and NFL-/- mice. Glia 52 (2005) 59-69
29. Strong M.J., and Garruto R.M. Isolation of fetal mouse motor neurons on discontinuous Percoll density gradients. In Vitro Cell Dev Biol 25 (1989) 939-945
30. Strong M.J., Sopper M.M., and He B.P. In vitro reactive nitrating species toxicity in dissociated spinal motor neurons from NFL (-/-) and hNFL (+/+) transgenic mice. Amyotroph Lateral Scler Other Motor Neuron Disord 11 (2003) 81-89
31. McLean I.W., and Nakane P.K. Periodate-lysince-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem 22 (1974) 1077-1083
32. Arundine M., Aarts M., Lau A., and Tymianski M. Vulnerability of central neurons to secondary insults after in vitro mechanical stretch. J Neurosci 24 (2004) 8106-8123
33. Sattler R., Charlton M.P., Hafner M., and Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem 71 (1998) 2349-2364
34. Randle J.C., Guet T., Bobichon C., Moreau C., Curutchet P., Lambolez B., et al. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-d-aspartate and non-N-methyl-d-aspartate receptor-mediated currents and synaptic potentials. Mol Pharmacol 41 (1992) 337-345
35. Grynkiewicz G., Poenie M., and Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440-3450
36. Eggett C.J., Crosier S., Manning P., Cookson M.R., Menzies F.M., McNeil C.J., et al. Development and characterisation of a glutamate-sensitive motor neuron cell line. J Neurochem 74 (2000) 1895-1902
37. Rothstein J.D. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 68 (1995) 7-20
38. Shaw P.J., and Ince P.G. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 244 (1997) S3-S14
39. Geiger J.R., Melcher T., Koh D.S., Sakmann B., Seeburg P.H., Jonas P., et al. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15 (1995) 193-204
40. Vandenberghe W., Ihle E.C., Patneau D.K., Robberecht W., and Brorson J.R. AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability. J Neurosci 20 (2000) 7158-7166
41. Greger I.H., Khatri L., and Ziff E.B. RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron 34 (2002) 759-772
42. Brorson J.R., Li D., and Suzuki T. Selective expression of heteromeric AMPA receptors driven by flip-flop differences. J Neurosci 24 (2004) 3461-3470
43. Ye B., Liao D., Zhang X., Zhang P., Dong H., and Huganir R.L. GRASP-1: a neuronal RasGEF associated with the AMPA receptor/GRIP complex. Neuron 26 (2000) 603-617
44. Van Damme P., Leyssen M., Callewaert G., Robberecht W., and Van Den B.L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett 343 (2003) 81-84
45. Maas S., Melcher T., and Seeburg P.H. Mammalian RNA-dependant deaminases and edited mRNAs. Curr Opin Cell Biol 9 (1997) 343-349
46. Morrison B.M., Janssen W.G., Gordon J.W., and Morrison J.H. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice. J Comp Neurol 395 (1998) 523-534
47. Feldmeyer D., Kask K., Brusa R., Kornau H.-C., Kolhekar R., Rozov A., et al. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat Neurosci 2 (1999) 57-64
48. Kask K., Zamanillo D., Rozov A., Burnashev N., Sprengel R., and Seeburg P.H. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function. Proc Natl Acad Sci U S A 95 (1998) 13777-13782
49. Kuner R., Groom A.J., Bresink I., Kornau H.-C., Stefovska V., Müller G., et al. Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A 102 (2005) 5826-5831
50. Tymianski M., Charlton M.P., Carlen P.L., and Tator C.H. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 13 (1993) 2085-2104
51. Choi Y.-B., Tenneti L., Le D.A., Ortiz J., Bai G., Chen H.-S.V., et al. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 3 (2000) 15-21
52. Ratnam J., and Teichberg V.I. Neurofilament-light increases the cell surface expression of the N-methyl-d-aspartate receptor and prevents its ubiquitination. J Neurochem 92 (2005) 878-885
53. Sattler R., and Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78 (2000) 3-13